Brief reportsRelation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation
References (13)
- et al.
American College of Cardiology/American Heart AssociationACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. (Writing Committee to Develop Data Standards on Atrial Fibrillation)
Circulation
(2004) - et al.
International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the working group on arrhythmias and the working group of cardiac pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology
J Cardiovasc Electrophysiol
(2003) - et al.
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements
Circulation
(1978) - et al.
C-reactive protein elevation in patients with atrial arrhythmias
Circulation
(2001) - et al.
The −174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillationIs atrial fibrillation an inflammatory complication?
Circulation
(2003) - et al.
Interleukin-6 endothelial activation and thrombogenesis in chronic atrial fibrillation
Eur Heart J
(2003)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2005 Excerpta Medica Inc. All rights reserved.